BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2157685)

  • 21. [Value and limits of conventional mediastinoscopy in preoperative evaluation of primary bronchial cancer].
    Robert J; Rochat T; Savioz D; Ludwig C; Spiliopoulos A
    Schweiz Med Wochenschr; 1998 Jun; 128(23):895-9. PubMed ID: 9658517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
    Gosney JR; Field JK; Gosney MA; Lye MD; Spandidos DA; Butt SA
    Anticancer Res; 1990; 10(3):623-8. PubMed ID: 2164348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bronchial cancer: new cell biology knowledge with relevance for diagnosis and therapy. A short review].
    Heinemann V; Jehn U
    Internist (Berl); 1985 Aug; 26(8):521-2. PubMed ID: 2865229
    [No Abstract]   [Full Text] [Related]  

  • 24. [Taxol in bronchial carcinoma].
    Gatzemeier U
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell loss and proliferation in non-small cell lung carcinoma: correlation with histological subtype.
    Mangili F; Cigala C; Arrigoni G; Rovere E; Gattuso C; Santambrogio G; Garancini P
    Eur J Histochem; 1998; 42(4):287-95. PubMed ID: 10068901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma with enlarged mediastinal and /or hilar lymph nodes].
    Wang MZ; Chen Y; Zhong W; Zhang L; Xu L; Shi JH; Zhong X; Xiao Y; Cai BQ; Li LY
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):533-5. PubMed ID: 17147121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymph- and haemangiosis carcinomatosa--an important prognostic factor in non-small-cell bronchial carcinoma (NSCLC)].
    Schultheis KH; Baumann M; Meyer W; Gebhardt C; Mittelmeier HO; Wünsch P
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():775-8. PubMed ID: 9101988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation between proliferative processes and cell death in non-small cell lung cancer with glandular differentiation at different stages of tumor progression].
    Kogan EA; Ugriumov DA
    Arkh Patol; 2002; 64(1):33-7. PubMed ID: 11889698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development and application of the method for controlling contamination of tumor samples with normal cells to detect deletion of P16 gene in primary lung carcinoma].
    Ran R; Cao XA; Tian Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):136-40. PubMed ID: 10072815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lymphadenectomy in the surgical treatment of bronchogenic carcinoma].
    Beltrami V; Bertagni A; Bosco MR; Covotta A; Gallinaro L; Montesano G; Nasti GA; Prece V
    Ann Ital Chir; 2000; 71(6):631-9. PubMed ID: 11347314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The international TNM classification of bronchopulmonary cancer].
    Bercea O
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):193-202. PubMed ID: 2855663
    [No Abstract]   [Full Text] [Related]  

  • 32. [Development and course of bronchial carcinoma].
    Dalquen P
    Schweiz Med Wochenschr; 1987 Sep; 117(39):1439-47. PubMed ID: 2823374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of plakoglobin in bronchial carcinomas: incidence and significance for disease outcome].
    Passlick B; Pantel K; Stosiek P; Hosch S; Thetter O; Izbicki JR
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():810-3. PubMed ID: 9101995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment results of the radiotherapy of advanced bronchial, breast and colorectal cancers].
    Schertel L; Mohring R; Tiersch C
    Rontgenpraxis; 1993 Mar; 46(3):81-8. PubMed ID: 8385806
    [No Abstract]   [Full Text] [Related]  

  • 35. [VATS (video-assisted thoracoscopic surgery): possibilities and limits of surgical therapy of malignant lung diseases].
    Stoelben E; Wehrmann U; Ockert D; Saeger HD
    Zentralbl Chir; 1998; 123(10):1129-33. PubMed ID: 9848249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor cord structure in human lung carcinoma.
    Kuwashima Y; Takemura T
    Igaku Kenkyu; 1993 Feb; 63(1):1-4. PubMed ID: 8392258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE; Kemp BL; Khuri FR; Kurie JM; Lee JS; Zhou X; Liu D; Hong WK; Mao L
    Cancer Res; 1999 Oct; 59(19):4798-803. PubMed ID: 10519387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incidence of metastatic lesion of different groups of the intrathoracic lymph nodes in lung cancer (based on research data on surgical preparations)].
    Vagner RI; Kuchava VO; Pozharisskiĭ KM
    Vopr Onkol; 1987; 33(2):27-33. PubMed ID: 3029993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchogenic carcinoma. A study of 109 cases.
    Jain NK; Madan A; Sharma TN; Agnihotri SP; Saxena A; Mandhana RG
    J Assoc Physicians India; 1989 Jun; 37(6):379-82. PubMed ID: 2556362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.